CE (Continuing Education)
-Free CE from www.powerpak.com
Appropriate Prescribing Practice with PPIs: Assessing Drug Interactions and the Benefit-Risk of Long-term Use
This activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and supported by an educational grant from Takeda Pharmaceuticals International Inc., US Region
John W. Devlin, Pharm.D., FCCM, FCCP
Professor, Department of Pharmacy Practice,
Bouve College, Northeastern University;
Special and Scientific Staff, Division of Pulmonary, Critical Care and Sleep Medicine,
Critical Care Pharmacist, Tufts Medical Center;
Colin W. Howden, MD
Professor of Medicine
Division of Gastroenterology
Northwestern University Feinberg School of Medicine
With expert insights from
Robert J. Chilton, DO, FACC
Department of Medicine, Division of Cardiology
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
Stuart H Ralston, MD, FRCP, FMedSci, FRSE
Arthritis Research UK Professor of Rheumatology
Molecular Medicine Centre
Western General Hospital
John W. Devlin, Pharm.D., FCCM, FCCP, has disclosed the following relevant affiliations or financial relationships with a commercial interest: Speaker's Bureau Takeda Pharmaceuticals.
Colin W. Howden, MD, has disclosed the following relevant affiliations or financial relationships with a commercial interest: Consultant Takeda Pharmaceuticals, Otsuka America Pharmaceutical, Inc , Ironwood Pharmaceuticals, Inc.; Speaker's Bureau Takeda Pharmaceuticals, Otsuka America Pharmaceutical, Inc , Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline.
Robert J. Chilton, DO, FACC,has no relevant affiliations or financial relationships with a commercial interest to disclose.
Stuart H Ralston, MD, FRCP, FMedSci, FRSE, has disclosed the following relevant affiliations or financial relationships with a commercial interest: Consultant Novartis Corporation, Merck & Co., Inc; Clinical Investigator Amgen Inc., Eli Lilly and Company.
Susanne Batesko, RN, BSN, Michele Salernitano, and Robin Carrino, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credits: 2.0 hours (0.20 ceu)
Type of Activity: Knowledge
Published: December 17, 2013
Expires: December 31, 2014
Fee Information: There is no fee for this educational activity.
Estimated time to complete activity: 120 minutes.